NCT03309891View on ClinicalTrials.gov

Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 18, 2016

Primary Completion Date

October 27, 2017

Study Completion Date

May 15, 2019

Conditions
Growth Hormone Deficiency
Interventions
DRUG

GX-H9

subcutaneous injection (weekly or twice-monthly)

DRUG

Genotropin

subcutaneous injection (daily)

Trial Locations (1)

Unknown

Odessa National Medical University, Odessa Regional Children's Hospital, Odesa

Sponsors

Lead Sponsor

Genexine, Inc.
All Listed Sponsors
lead

Genexine, Inc.

INDUSTRY

NCT03309891 - Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency | Biotech Hunter | Biotech Hunter